Targeted Oncology22 小时
Breakthroughs, Personalization, and the Future of Lymphoma Care
Ann LaCasce, MD, MMSc, delved into some of the most recent advances in the lymphoma space, exploring how these new therapies ...
Targeted Oncology22 小时
Five-Year Data Confirm Benefit of Nivolumab in Upper GI Cancer
David B. Zhen, MD, discusses the results of the phase 3 CheckMate 649 trial in patients with advanced gastric cancer, ...
Targeted Oncology4 小时
Future Directions After AURIGA: Daratumumab and Lenalidomide in Myeloma
Ashraf Z. Badros, MB, ChB, discusses the next steps following the phase 3 AURIGA trial of daratumumab and lenalidomide vs lenalidomide maintenance in patients with newly diagnosed multiple myeloma.